Graft vs. Host Disease – Society of Cannabis Clinicians https://www.cannabisclinicians.org Educating Healthcare Professionals about the Medical Use of Cannabis Fri, 04 Dec 2020 20:16:37 +0000 en-US hourly 1 https://wordpress.org/?v=6.2.3 https://www.cannabisclinicians.org/wp-content/uploads/2020/07/cropped-scc-flavicon-32x32.png Graft vs. Host Disease – Society of Cannabis Clinicians https://www.cannabisclinicians.org 32 32 Signaling Through the Type 2 Cannabinoid Receptor Regulates the Severity of Acute and Chronic Graft versus Host Disease https://www.cannabisclinicians.org/2020/11/09/signaling-through-the-type-2-cannabinoid-receptor-regulates-the-severity-of-acute-and-chronic-graft-versus-host-disease/ Mon, 09 Nov 2020 21:20:50 +0000 https://www.cannabisclinicians.org/?p=20500 Authors: Cheng Yin Yuan, Vivian Zhou, Garrett Sauber, Todd M Stollenwerk, Richard Komorowski, Alicia López, Rosa Maria Tolon, Julian Romero, Cecilia J Hillard, William R Drobyski Published in Blood  October...

The post Signaling Through the Type 2 Cannabinoid Receptor Regulates the Severity of Acute and Chronic Graft versus Host Disease appeared first on Society of Cannabis Clinicians.

]]> Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study. https://www.cannabisclinicians.org/2015/10/01/cannabidiol-for-the-prevention-of-graft-versus-host-disease-after-allogeneic-hematopoietic-cell-transplantation-results-of-a-phase-ii-study/ Thu, 01 Oct 2015 19:41:08 +0000 https://www.cannabisclinicians.org/?p=14698 Authors: Moshe Yeshurun, Ofer Shpilberg, Corina Herscovici, Liat Shargian, Juliet Dreyer, et al
Biology of Blood and Marrow Transplantation, October 2015
---
Graft-versus-host-disease (GVHD) is a major obstacle to successful allogeneic hematopoietic cell transplantation (alloHCT). Cannabidiol (CBD), a nonpsychotropic ingredient of Cannabis sativa, possesses potent anti-inflammatory and immunosuppressive properties. We hypothesized...

The post Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study. appeared first on Society of Cannabis Clinicians.

]]> Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: evidence from an experimental murine model. https://www.cannabisclinicians.org/2011/09/01/targeting-cannabinoid-receptors-as-a-novel-approach-in-the-treatment-of-graft-versus-host-disease-evidence-from-an-experimental-murine-model/ Thu, 01 Sep 2011 13:14:32 +0000 https://www.cannabisclinicians.org/?p=14721 Authors: Rupal Pandey, Venkatesh L. Hegde, Mitzi Nagarkatti, Prakash S. Nagarkatti
Journal of Pharmacology and Experimental Therapeutics, September 2011
---
Allogeneic hematopoietic cell transplantation (HCT) is widely used to treat patients with life-threatening malignant and nonmalignant hematological diseases. However, allogeneic HCT often is accompanied by severe and lethal complications from graft-versus-host disease (GVHD)...

The post Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: evidence from an experimental murine model. appeared first on Society of Cannabis Clinicians.

]]>